Recent News

• 05.07.2025 - ADMA Biologics 1Q 2025 Earnings Call
• 05.07.2025 - ADMA Biologics 1Q 2025 Earnings Call
• 05.07.2025 - ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
• 05.07.2025 - ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
• 05.07.2025 - ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
• 04.30.2025 - ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
• 04.30.2025 - ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
• 04.30.2025 - ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
• 04.28.2025 - ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
• 04.28.2025 - ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

Recent Filings

• 05.07.2025 - 8-K Current report
• 05.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2025 - EX-99.1 EX-99.1
• 04.30.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.28.2025 - EX-99.1 EX-99.1
• 04.28.2025 - 8-K Current report
• 04.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.15.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.15.2025 - ARS Annual Report to Security Holders